Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579644 · ClinicalTrials.gov registry record · Phase 3
Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone
A Phase 3 study, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 3
- Development phase
- 91
- Enrollment target
NCT00579644 is a Phase 3 study that has completed, run by University of Nebraska. The registered enrollment target is 91 participants.
The verdict
NCT00579644, a Phase 3 study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a combination of methotrexate and minocycline works better than methotrexate alone in early Rheumatoid Arthritis
Interventions
- DRUG methotrexate
- DRUG Combination of Minocycline and MTX or MTX alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2001-03-28 |
| Est. Completion | 2006-05-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579644
The ClinicalTrials.gov registry entry for NCT00579644 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which methotrexate is the first listed.
NCT00579644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579644 about?
NCT00579644 is a clinical study titled "Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone". The purpose of this study is to determine if a combination of methotrexate and minocycline works better than methotrexate alone in early Rheumatoid Arthritis
What is the current status of trial NCT00579644?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 91 participants. The study started on 2001-03-28. Estimated completion is 2006-05-31.
What interventions are being tested in trial NCT00579644?
The interventions under investigation include: methotrexate (DRUG), Combination of Minocycline and MTX or MTX alone (DRUG).
Who is sponsoring clinical trial NCT00579644?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.